• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
Home
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
Search Icon
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Pharma
    • Asia
    • Drug Delivery
    • Executives
    • Clinical Data
  • Vaccines
  • Special Reports
  • Trending
    • COVID-19
    • Cell & Gene Therapy
  • Podcasts
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events

Samsung

Manufacturing

For $323M, Samsung Bio purchases land to increase CDMO footprint

Samsung has acquired additional land in South Korea to construct a new duplicate facility. The parcel was purchased for $323 million.
Kevin Dunleavy Jul 18, 2022 4:53pm

AstraZeneca, Takeda, Biogen, Samsung and more—Fierce Pharma Asia

Feb 4, 2022 6:26am

Samsung unit denies report about Biogen buyout talks

Dec 30, 2021 8:13am

Biogen shares jump on $42 billion Samsung buyout reports

Dec 29, 2021 3:08pm

Samsung, Moderna, Brii and more—Fierce Pharma Asia

Aug 27, 2021 9:20am

JSR's CDMO arm plots $150M Research Triangle biologics plant

Dec 3, 2020 8:35am
Home
  • Connect
    • The Team
    • Advertise
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2023 Questex LLC All rights reserved.
Terms of use
Privacy Policy